scope:

This draft European Standard provides the procedure for the specific assessment required in 122 EN 50527-1:2016, Annex A, for workers with implanted cardioverter defibrillators (ICDs) and Cardiac 123 Resynchronization Therapy devices with associated defibrillation functions (CRT-D). Only devices of this 124 type equipped with leads implanted transvenously are considered. It offers different approaches for doing the 125 risk assessment. The purpose of the specific assessment is to determine the risk for workers with implanted ICDs and CRT-Ds 131 arising from exposure to electromagnetic fields at the workplace. The assessment includes the likelihood of 132 clinically significant effects and takes account of both transient and long-term exposure within specific areas 133 of the workplace. The techniques described in the different approaches may also be used for the assessment of publicly 136 accessible areas. 137 The frequency range to be observed is from 0 Hz to 3 GHz. Above 3 GHz no interference with the devices 138 within the scope of this Particular Standard is expected to occur when the exposure limits are not exceeded.